A Phase II Study of Prolonged Oral Etoposide in Advanced or Recurrent Carcinoma of the Cervix

By Morris M.   Brader K.R.   Burke T.W.   Levenback C.F.   Gershenson D.M.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 215-218

Elsevier

Access to resources Recommend Favorite

EORTC Group phase II study of oral etoposide for pretreated soft

By Keizer H. Jan   Crowther Derek   Nielsen Ole Steen   Oosterom Allan T. Van   Muguiro Javier Hornedo   Pottelberghe Christine Van   Somers Renier   Tursz Thomas  

Sarcoma, Vol. 1, Iss. 2, 1997-06 ,pp. : 99-102

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors

By Ruggiero Antonio  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 513-518

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma: A Southwest Oncology Group Study

By Poplin E.A.   Liu P.Y.   Delmore J.E.   Wilczynski S.   Moore D.F.   Potkul R.K.   Fine B.A.   Hannigan E.V.   Alberts D.S.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 432-435

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Lewandowski G.S.   Creasman W.T.   Webster K.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite